Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Moderna, Inc.

CAMBRIDGE, Mass. --(BUSINESS WIRE)--Oct. 31, 2021-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided an update that the U.S. Food and Drug Administration (FDA) has notified the Company that it will require additional